Rchr
J-GLOBAL ID:202401004088034679
Update date: Mar. 24, 2025 Abe Kohtaro
アベ コウタロウ | Abe Kohtaro
Affiliation and department: Job title:
Professor and Chairman
Research theme for competitive and other funds (10): - 2023 - 2027 胸部X線動態撮影と人工知能を組み合わせた全自動式肺塞栓症診断システムの開発
- 2023 - 2026 Novel Mechanisms of Inflammation in Pulmonary Hypertension
- 2020 - 2023 A novel therapy of pulmonary hypertension targeting degradation of altered mitochodoria
- 2017 - 2020 The role of inflammation on the development of occlusive lesions in pulmonary arterial hypertension
- 2016 - 2019 Development of novel therapeutic strategy for the treatment of pulmonary hypertension by targeting thrombin receptor
- 2015 - 2017 Development of non-invasive MRI assessment for chronic thromboembolic pulmonary hypertension
- 2014 - 2017 The Role of Hemodynamic Stress in the Development/Maintenance of Occlusive Vascular Lesions in Severe Pulmonary Hypertension
- 2012 - 2015 Novel aspects for the role and therapy of autonomic nervous system in pulmonary hypertension toward right ventricular heart failure
- 2012 - 2014 The pathogenesis of bone marrow-derived progenitor cells in the novel preclinical PAH model
- 2011 - 2013 Elucidation of roles of proteinase-activated receptor in pulmonary hypertension and development of new therapeutic strategies
Show all
Papers (53): -
Junichi Nakamura, Ichizo Tsujino, Kohei Masaki, Kazuya Hosokawa, Kouta Funakoshi, Yu Taniguchi, Shiro Adachi, Takumi Inami, Jun Yamashita, Hitoshi Ogino, et al. Cancer as an independent mortality risk in chronic thromboembolic pulmonary hypertension. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2025. 44. 3. 339-348
-
Tae Higuchi, Tomomi Ide, Takeo Fujino, Takeshi Tohyama, Yuta Nagatomi, Tomoyuki Nezu, Masataka Ikeda, Toru Hashimoto, Shouji Matsushima, Keisuke Shinohara, et al. Clinical characteristics and predictive biomarkers of intensive care unit-acquired weakness in patients with cardiogenic shock requiring mechanical circulatory support. Scientific reports. 2025. 15. 1. 3535-3535
-
Nobutaka Ikeda, Kohei Masaki, Kazuya Hosokawa, Kouta Funakoshi, Yu Taniguchi, Shiro Adachi, Takumi Inami, Jun Yamashita, Hitoshi Ogino, Ichizo Tsujino, et al. Insights into balloon pulmonary angioplasty and the WHO functional class of chronic thromboembolic pulmonary hypertension patients: findings from the CTEPH AC registry. Cardiovascular intervention and therapeutics. 2025
-
Takeshi Tohyama, Takeshi Iwasaki, Masataka Ikeda, Masato Katsuki, Tatsuya Watanabe, Kayo Misumi, Keisuke Shinohara, Takeo Fujino, Toru Hashimoto, Shouji Matsushima, et al. Deep learning model to diagnose cardiac amyloidosis from haematoxylin/eosin-stained myocardial tissue. European heart journal. Imaging methods and practice. 2025. 3. 1. qyae141
-
Yuzo Yamasaki, Kazuya Hosokawa, Takeshi Kamitani, Kohtaro Abe, Koji Sagiyama, Takuya Hino, Megumi Ikeda, Shunsuke Nishimura, Hiroyuki Toyoda, Shohei Moriyama, et al. Diagnostic accuracy and added value of dynamic chest radiography in detecting pulmonary embolism: A retrospective study. European journal of radiology open. 2024. 13. 100602-100602
more... MISC (163): -
池田 昌隆, 井手 友美, 阿部 弘太郎. 【フェロトーシス(鉄依存性細胞死)-そのメカニズムの解明と,治療への応用】アントラサイクリン心毒性におけるフェロトーシス. 医学のあゆみ. 2024. 290. 2. 178-181
-
桑原 政成, 阿部 弘太郎. 【高尿酸血症2024-基礎・臨床の最新知見-】高尿酸血症の臨床 高尿酸血症の治療 薬物療法 無症候性高尿酸血症の治療. 日本臨床. 2024. 82. 6. 917-923
-
阿部 弘太郎. 当院における血栓塞栓症への取り組み. 日本医療マネジメント学会雑誌. 2024. 25. Suppl. 354-354
-
阿部 弘太郎, 細川 和也. 肺高血圧診断基準変更の意義 CTEPH/CTEPDにおける診断基準変更は治療戦略に影響がでるか?. 日本心臓病学会学術集会抄録. 2023. 71回. S6-2
-
阿部 弘太郎, 細川 和也. 本邦から世界へ向けたAll-Japan肺高血圧症レジストリの展望 All Japan CTEPH AC Registryの現在と未来. 日本肺高血圧・肺循環学会学術集会抄録集. 2023. 8回. 44-44
more... Patents (4): Return to Previous Page